Instant Insights – CRISPR

Prescriber Perceptions around CRISPR in 2023

Four years ago, InCrowd assessed the awareness among physicians of nucleic acid-based therapies, their mechanisms of action, and their current and future promise.
In considering the 2019 research, InCrowd wanted to understand any change in awareness of these therapies and then examine specific perceptions around CRISPR.

This research reflects the comparisons of awareness between 2019 and 2023 of nucleic acid-based therapies with a specific focus on CRISPR.

What you’ll learn:

Our 2023 report includes responses from over 100 qualified US-based healthcare professionals (HCPs) familiar with the therapies considered in the research.

Explore respondents:

Awareness of CRISPR and mRNA
Optimism and concerns regarding the widespread use of CRISPR
Comfort level recommending and administering CRISPR to patients

Get our key takeaways. Download the report today.

We’re introducing a new era of healthcare market research — one that’s faster, smarter, and more connected.

Download our ebook, “The Evolution of Market Research in Healthcare,” to discover the trends redefining the field and how Konovo is helping companies turn insight into action.